Yahoo · Nov 12, 2026
VETmAb Biosciences Appoints Katja Buhrer as Chief Operating Officer
SAN DIEGO, Nov. 12, 2026 (GLOBE NEWSWIRE) -- VETmAb Biosciences (VETmAb BIO), a clinical-stage biopharmaceutical company developing transformative biologics for pets, today announced the appointment of Katja Buhrer as Chief Operating Officer. Ms. Buhrer brings operational and strategic leadership experience across animal and human biotechnology, including as a senior executive at Kindred Biosciences (KindredBio), where she worked alongside members of VETmAb BIO’s founding team. Ms. Buhrer previo

